Both companies have weathered their latest mixed financial results, and their shares are now back on the rise. Which is the more compelling buy at current levels?
Levi Strauss opens for trading Thursday on the New York Stock Exchange at $22.22, sharply above its $17 a share initial public offering price.
Biogen shares plunge Thursday, wiping nearly $20 billion in value from the biotech group, after it dropped a late-stage trial for a key Alzheimer's disease drug.
Apple shares rises after three analysts' upgrades for the world's biggest tech company ahead of its much-anticipated launch event next week in Cupertino.
Buying gold is easier than you may think - but you have to do your homework first.
Jim Cramer's not looking forward to Apple's event. Here's why.
The social network said that the passwords were stored internally in a format that was readable by company employees.
March is here! Find out if your tournament bracket can top Jim Cramer's.
Company executives anticipate a poor first quarter in the new fiscal year.